| dronabinol oral / Generic mfg. |
| Recruiting | 2a | 20 | RoW | SCI -110, Dronabinol and PEA | The Israeli Medical Center for Alzheimer's | Alzheimer Disease | 06/23 | 06/23 | | |
| Recruiting | 2 | 250 | | | Palliative Care Clinical Studies Collaborative, NSW Health | Cancer-related anorexia | | | | |
2006-004482-33: Investigating the acute effects of THC on functional brain systems |
|
|
| Ongoing | 2 | 21 | Europe | Dronabinol, | University Medical Center Utrecht | This research project will be performed with healthy volunteers in order to determine whether THC modulates activity in functional brain systems. | | | | |
2017-004226-15: Can-ArtEffect and safety of using Canabis derivatives for the treatment of pain in patients with inflammatory Arthritis, such as reumatoid arthritis and ankylosing spondylitis, the latter being a type of arthritis that causes a long term inflammation of the joints of the spine. A randomized, double blinded, placebo controlled trial, i.e. in this drug trial, a control group is given a placebo while another group is given the Cannabis derivative being studied. Can-ArtEffekt og sikkerhed ved anvendelse af Canabis-derivater til behandling af smerte hos patienter med inflammatorisk arthritis, såsom rheumatoid arthritis og ankyloserende spondylitis (sidstnævnte er en type arthritis, der forårsager langvarig betændelse i rygsøjlen og bækkenet).En randomiseret, dobbeltblindet, placebokontrolleret forsøg, dvs. i denne lægemiddelforsøg, gives en kontrolgruppe en placebo, mens en anden gruppe får substansen, der undersøges, dvs. Cannabis derivatet. |
|
|
| Ongoing | 2 | 180 | Europe | Cannabidiol tablet 10 mg, Dronabinol capsule 2.5. mg, Tablet, Capsule | King Christian 10th Hospital for Rheumatology, The Danish Rheumatism Association, The Region of Southern Denmark | Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS), RA and AS are autoimmune diseases. In RA the immune system attacks the membranes lining the joints, typically initially in small joints. AS affects the joints of the spine and the pelvic girdle., Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2017-004823-66: Early-life stress, the endocannabinoid system, and fear memory extinction |
|
|
| Ongoing | 2 | 48 | Europe | Namisol, Hydrocortison CF, ECP002A, RVG 50730, Tablet, Hydrocortison CF | Radboudumc, Radboudumc | healthy volunteers gezonde vrijwilligers, intended indication: posttraumatic stress disorder (PTSD) beoogde indicatie: posttraumatic stress disorder (PTSD), Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2018-000014-38: A Phase IIa Study to Determine the Safety, Tolerability and Efficacy of a daily oral dose of THX-110 in Adult Patients with Tourette Syndrome (TS) |
|
|
| Not yet recruiting | 2 | 60 | Europe | THX-110 [Dronabinol], THX-110 [PEA (Palmitoylethanolamide)], Capsule, soft, Tablet, Dronabinol Capsules, USP | Therapix Biosciences Ltd., Therapix Biosciences Ltd. | Tourette Syndrome, Neuropsychiatric disorder characterized by multiple motor or vocal tics., Diseases [C] - Nervous System Diseases [C10] | | | | |
| Ongoing | 2 | 100 | Europe | ANEB001, NAMISOL®, ANEB001, Capsule, soft, Tablet | Anebulo pharmaceuticals, Inc., Anebulo pharmaceuticals, Inc. | THC intoxication, THC overdose, Not possible to specify | | | | |
| Recruiting | 2 | 100 | Europe | Dronabinol 5 MG, Dronabinol 10 MG, Placebo | Medical University of Vienna | Retinal Blood Flow | 10/23 | 10/23 | | |
| Completed | 2 | 75 | US | Dronabinol (Marinol®), Placebo | Johns Hopkins University, Mclean Hospital, Miami Jewish Health, National Institute on Aging (NIA), Tufts Medical Center | Alzheimer's Disease | 05/24 | 05/24 | | |
| Recruiting | 2 | 75 | US | Dronabinol, Marinol, delta-9-tetrahydrocannabinol, Placebo | Christopher D. Verrico | Low Back Pain, Chronic Pain, Back Injuries | 12/26 | 12/27 | | |
NCT06446479: Effects of THC on Alcohol Consumption and Neural Correlates of Reward |
|
|
| Not yet recruiting | 2 | 28 | NA | Dronabinol Pill, Placebo | University of Colorado, Denver, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Colorado State University | Cannabis Use Disorder | 06/26 | 06/26 | | |
NCT04992624: Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee |
|
|
| Recruiting | 2 | 200 | US | Placebo, Cannabidiol (CBD), Epidiolex, Tetrahydrocannabinol (Marinol® or generic equivalent (e.g., dronabinol), Dronabinol | Steven E Harte, PhD, National Center for Complementary and Integrative Health (NCCIH), National Institute on Drug Abuse (NIDA) | Osteoarthritis, Knee, Osteoarthritis of the Knee | 10/26 | 10/26 | | |
NCT05477875: Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control |
|
|
| Recruiting | 2 | 35 | US | oral cannabinoid, dronabinol, oral codeine/acetaminophen | University of Florida, Consortium for Medical Marijuana Clinical Outcomes Research | Photorefractive Keratectomy, Myopia, Hyperopia | 09/25 | 09/25 | | |
NCT04620512: Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee |
|
|
| Not yet recruiting | 2 | 200 | US | Placebo, THC 10 mg/day, dronabinol, Marinol, CBD 150 mg/day, Epidiolex®, CBD 150 mg/day plus THC 10 mg/day | Richard Harris, National Institute on Drug Abuse (NIDA), National Center for Complementary and Integrative Health (NCCIH) | Osteoarthritis, Knee | 10/25 | 10/25 | | |
CRISP, NCT05519111: Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain |
|
|
| Enrolling by invitation | 2 | 60 | US | Dronabinol, Marinol, Placebo | Icahn School of Medicine at Mount Sinai, National Heart, Lung, and Blood Institute (NHLBI) | Sickle Cell Disease | 06/26 | 06/26 | | |
NCT05612711: Dronabinol for Agitation in Dementia Crossover Trial |
|
|
| Not yet recruiting | 2 | 50 | US | Dronabinol, Marinol | Ralph H. Johnson VA Medical Center, JHSPH Center for Clinical Trials | Dementia Moderate, Dementia Severe, Agitation,Psychomotor, Behavioral Symptoms | 11/25 | 11/26 | | |
NCT05269628: Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype |
|
|
| Recruiting | 2 | 166 | US | Cannabidiol (CBD), Epidiolex®, Tetrahydrocannabinol (THC), Marinol®, dronabinol, Placebo CBD, Placebo THC | Tiffany J. Braley, MD, MS, National Center for Complementary and Integrative Health (NCCIH) | Multiple Sclerosis, Sleep, Pain | 06/26 | 06/26 | | |
NCT05351801: Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain |
|
|
| Active, not recruiting | 2 | 21 | US | THC (Dronabinol), CBD (Epidolex), THC + CBD (Nabiximols), Placebo | VA Office of Research and Development | Diabetic Neuropathic Pain | 06/27 | 06/27 | | |
NCT05272865: Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC |
|
|
| Not yet recruiting | 1/2 | 334 | RoW | Pharmacokinetic and pharmacodynamic profile of THC oral formulations with Dronabinol as comparator, Administration of different Cannabis oral formulations with THC as compared with Active comparator (DRONABINOL) | LaSanta S A S | Nausea Post Chemotherapy, Vomiting, Cancer Pain, Cancer Related Pain, Neoplasms | 02/24 | 10/24 | | |
| Not yet recruiting | 1/2 | 120 | US | Dronabinol, Marinol | VA Office of Research and Development, University of Illinois at Chicago | Obstructive Sleep Apnea | 09/26 | 12/26 | | |
